CN117430738A - Catalyst component for olefin polymerization, catalyst and application thereof - Google Patents

Catalyst component for olefin polymerization, catalyst and application thereof Download PDF

Info

Publication number
CN117430738A
CN117430738A CN202210827412.7A CN202210827412A CN117430738A CN 117430738 A CN117430738 A CN 117430738A CN 202210827412 A CN202210827412 A CN 202210827412A CN 117430738 A CN117430738 A CN 117430738A
Authority
CN
China
Prior art keywords
benzimidazole
carboxylic acid
methyl ester
acid methyl
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210827412.7A
Other languages
Chinese (zh)
Inventor
何世雄
蔡晓霞
庄庄
刘海涛
马吉星
李昌秀
胡建军
许景琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinopec Beijing Chemical Research Institute Co ltd
China Petroleum and Chemical Corp
Original Assignee
Sinopec Beijing Chemical Research Institute Co ltd
China Petroleum and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinopec Beijing Chemical Research Institute Co ltd, China Petroleum and Chemical Corp filed Critical Sinopec Beijing Chemical Research Institute Co ltd
Priority to CN202210827412.7A priority Critical patent/CN117430738A/en
Publication of CN117430738A publication Critical patent/CN117430738A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/04Monomers containing three or four carbon atoms
    • C08F110/06Propene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides a catalyst component for olefin polymerization, a catalyst and application thereof, wherein the catalyst component contains magnesium, titanium, halogen and an internal electron donor, the internal electron donor is a compound shown in a general formula I, the structure of the compound shown in the general formula I is as follows,in the general formula I, R 2 ~R 5 The same or different is hydrogen, C1-C30 alkyl, C2-C30 alkenyl, C6-C30 aryl, C4-C30 heterocyclic group, halogen atom, alkoxy or substituent containing nitrogen atom; r is R 1 、R 6 The same or different are hydrogen, C1-C15 aliphatic chains or substituent groups containing hetero atoms; the hetero atoms being selected from nitrogen, sulfur, oxygen, phosphorusAnd at least one of silicon. The polymer prepared by the catalyst containing the catalyst component has higher melt index and wide molecular weight distribution, and can effectively improve the processability of products.

Description

Catalyst component for olefin polymerization, catalyst and application thereof
Technical Field
The invention belongs to the field of olefin polymerization, and particularly relates to a catalyst component for olefin polymerization, a catalyst and application thereof.
Background
The internal electron donor is an important component of Ziegler-Natta polyolefin catalysts, and plays a decisive role in the catalytic activity of the catalysts, the hydrogen regulation sensitivity and the molecular weight distribution of the polyolefin products. In the current common industrial catalysts, the internal electron donor is mostly phthalate compounds. With the increasing interest in health, as one of the common industrial plasticizers, the application of plastic products containing phthalate compounds is greatly limited, and in particular, the european union REACH regulations have adopted stricter limitation measures for plasticizers in 2019, and this act requires all plastic products exported to the european union, wherein the content of the plasticizer is increased from the original content of each plasticizer to 0.1% or less, and the total content of several plasticizers is increased to 0.1% or less. The related national standard GB/T29498-2020 is also implemented in China to standardize the use of phthalate compounds in consumer products for limitation. Therefore, in the development of new polyolefin Ziegler-Natta catalyst technology, catalysts containing no phthalate compounds have become fundamental requirements for many aspects such as green, health, and environmental protection. At present, various novel internal electron donor compounds have been developed for replacing phthalate compounds, and mainly diether compounds (such as 1, 3-diether, see patent CN 1463274A), dicarboxylic acid ester compounds (such as succinate, see patent CN1313869 a) and glycol ester compounds (such as 1, 3-glycol ester, see patent CN1436766 a) are common.
In recent years, a number of electron donor compounds of novel structures have been developed for olefin polymerization catalysts, and among them, a class of compounds other than plasticizers has a nitrogen atom structure in its molecular structure, and has been attracting attention as an internal electron donor preparation catalyst. The nitrogen atoms exist in a mode of forming fatty amine, and exist in the structure of fatty chain or N-alkyl heterocycle according to the chemical bond of the unequal SP3 hybridization structure, for example, a substituted fatty amine group/amide ester compound, such as the compound shown in patent CN101104589A and patent US2012322962, and the compound is used as a catalyst for preparing an internal electron donor, so that the defects of low orientation capability or high xylene soluble content of the prepared polymer exist; functional groups such as aromatic amine and imine can also be formed, and chemical bonds with an equal or unequal SP2 hybridization structure exist in five-membered or six-membered nitrogen aromatic heterocycle or substituent groups at alpha position, such as compounds disclosed in patent CN112759531A and patent CN105085746B, but the prepared catalyst has the problem of low orientation capability or lower melt index of the product; cyano (-CN) can also be formed and exists in the compound in an unequal SP hybridization mode, for example, a cyano ketone compound disclosed in patent CN1715301A and a cyano ester compound disclosed in patent CN1242780A are adopted as polyolefin catalysts, the catalysts remain in plastic products in the olefin polymerization process, and if the products have trace decomposition in the use process, the generated toxic free cyanide is extremely easy to cause harm to human health. Therefore, for the application of nitrogen-containing internal electron donors of non-plasticizers in the field, there is still a need to improve the catalyst and its components so as to make them have better directing ability and catalytic activity and make the prepared product more suitable for downstream product processing.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a catalyst component for olefin polymerization, a catalyst containing the catalyst component and application thereof, wherein an organic compound containing benzimidazole structures is introduced into the catalyst component as an internal electron donor, the internal electron donor does not contain plasticizers, nitrogen atoms in the internal electron donor simultaneously contain SP2 and SP3 for hybridization, and the obtained catalyst containing the catalyst component has high activity and good stereospecificity, and particularly the prepared polymer has wide molecular weight distribution and can effectively improve the processability of products.
In a first aspect, the invention provides a catalyst component for olefin polymerization, wherein the catalyst component contains magnesium, titanium, halogen and an internal electron donor, the internal electron donor is a compound shown in a general formula I, the structure of the compound shown in the general formula I is as follows,
in the general formula I, R 2 ~R 5 The same or different is hydrogen, C1-C30 alkyl, C2-C30 alkenyl, C6-C30 halogen substituted or unsubstituted aryl, C4-C30 heterocyclic group, halogen atom, alkoxy or substituent containing nitrogen atom; r is R 1 、R 6 The same or different is hydrogen, C1-C15 alkyl or substituent containing hetero atom; the heteroatom is selected from at least one of nitrogen, sulfur, oxygen, phosphorus, and silicon.
As a specific embodiment of the present invention, preferably, in formula I, R 2 ~R 5 The same or different, each independently is a C1-C10 alkyl group, a C2-C15 alkenyl group, a C6-C15 halogen substituted or unsubstituted aromatic group, a C4-C15 heterocyclic group, a halogen atom, an alkoxy group or a substituent containing a nitrogen atom; preferably, each is independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl, methoxy, isopropyl ether, tert-butyl ether, phenyl, halophenyl, naphthyl, biphenyl, nitro, amino, pyridine, thiophene, or quinoline.
As a specific embodiment of the present invention, preferably, in formula I, R 6 is-O-R 7 or-N-R 8 (-R 9 ) Wherein R is 7 、R 8 And R is 9 Each independently is hydrogen, a C1-C30 alkyl group, a C2-C30 alkenyl group, a C6-C30 halogen substituted or unsubstituted aryl group, a C4-C30 heterocyclic group, a halogen atom, an alkoxy group, or a substituent containing a nitrogen atom; preferably, R 7 、R 8 And R is 9 Each independently is hydrogen, C1-C10 alkyl, C2-C15 alkenyl, C6-C15 halogen substituted or unsubstituted aryl, C4-C15 heterocyclic, halogen atom, nitro, amino or alkoxy.
As a specific embodiment of the present invention, preferably, the catalyst component has a magnesium element content of 1wt% to 89.7wt%, a titanium element content of 0.2wt% to 20wt%, a halogen content of 10wt% to 80wt%, and an internal electron donor content of 0.1wt% to 30wt%, based on the mass of the catalyst component; more preferably, the content of magnesium element is 10-45 wt%, the content of titanium element is 1.5-10 wt%, the content of halogen is 20-45 wt%, and the content of internal electron donor is 1-15 wt%; still more preferably, the content of magnesium element is 15wt% to 25wt%, the content of titanium element is 2wt% to 5wt%, the content of halogen is 30wt% to 41wt%, and the content of internal electron donor is 5wt% to 13wt%.
As a specific embodiment of the present invention, the compound represented by the general formula I is preferably selected from the group consisting of 1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-diphenyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-ethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-ethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-ethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (2-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (3-ethylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (2-n-propylphenyl) -1-carboxylic acid methyl ester, 1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (2-isopropylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4, 6-trimethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (4-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (4-isopropylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (2, 4-dimethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (2, 4, 6-trimethylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (2-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-1-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (2-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-nitrophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4, 6-trinitrophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-dimethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-diethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-isopropyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-di-n-butyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-di-isobutyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-trinitrophenyl-1-carboxylic acid methyl ester, 5, 6-dimethyl-1-benzimidazole-carboxylic acid methyl ester, 5, 6-dimethyl-1-carboxylic acid methyl ester, 5, 1-dimethyl-1-benzimidazole-carboxylic acid methyl ester, 5, 1-dimethyl-1-carboxylic acid methyl ester, 5, 6-bis (1-methylpentyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-n-pentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-dipentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-butyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-dimethyl-6-isobutyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-pentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-isopentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-ethyl-6-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 6-methyl-1H-benzimidazole-carboxylic acid methyl ester, 6-methyl-1-isopropyl-1-benzimidazole-carboxylic acid methyl ester, 6-nitro-1-benzimidazole-1-carboxylic acid methyl ester, 6-n-butyl-1H-benzimidazole-carboxylic acid methyl ester, 5-dimethyl-1-isobutyl 1-carboxylic acid methyl ester, 5-dimethyl-1H-benzimidazole-carboxylic acid methyl ester, 5-methyl-isopentyl-1-benzimidazole-carboxylic acid methyl ester, 5-methyl-1-isopropyl-1-carboxylic acid, 1,1' -carbonylbis (5-methyl-1H-benzimidazole), 1' -carbonylbis (5-ethyl-1H-benzimidazole), 1' -carbonylbis (5-isopropyl-1H-benzimidazole), 1-phenyl-1 ' - (1H-benzimidazolyl) -methanone, 1- (1H-imidazolyl) -1' - (1H-benzimidazolyl) -methanone, 1- (5-methyl-1H-imidazolyl) -1' - (5-methyl-1H-benzimidazolyl) -methanone, 1- (2-ethyl-3-methyl-1H-imidazolyl) -1' - (1H-benzimidazolyl) -methanone, 1H-benzimidazole-1-carboxamide, N, N-diphenyl-1H-benzimidazole-1-carboxamide, N-bis (4-methylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-methylphenyl) -1H-benzimidazole-1-carboxamide, 4, 5-bis (3-methylphenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2, 4-methylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (4-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (4-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (2, 4-dimethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-chlorophenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-chlorophenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-chlorophenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-nitrophenyl) -1H-benzimidazole-1-carboxamide, N-dimethyl-1H-benzimidazole-1-carboxamide, N-diethyl-1H-benzimidazole-1-carboxamide, N-di-N-propyl-1H-benzimidazole-1-carboxamide, N, N-diisopropyl-1H-benzimidazole-1-carboxamide, N-di-N-butyl-1H-benzimidazole-1-carboxamide, N-diisobutyl-1H-benzimidazole-1-carboxamide, N, n-bis (1-methylpropyl) -1H-benzimidazole-1-carboxamide, N-bis (1-methylbutyl) -1H-benzimidazole-1-carboxamide, N-bis (1-methylpentyl) -1H-benzimidazole-1-carboxamide, N-di-N-pentyl-1H-benzimidazole-1-carboxamide, N, N-dipentyl-1H-benzimidazole-1-carboxamide, N-methyl-N-N-propyl-1H-benzimidazole-1-carboxamide, N-methyl-N-isopropyl-1H-benzimidazole-1-carboxamide, N-methyl-N-N-butyl-1H-benzimidazole-1-carboxamide, ethyl 1H-benzimidazole-1-carboxylate, trifluoroethyl 1H-benzimidazole-1-carboxylate, propyl 1H-benzimidazole-1-carboxylate, N-butyl 1H-benzimidazole-1-carboxylate, isobutyl 1H-benzimidazole-1-carboxylate, N-pentyl 1H-benzimidazole-1-carboxylate, isopentyl 1H-benzimidazole-1-carboxylate, 2-methylbutyl 1H-benzimidazole-1-carboxylate, 2-dimethylpropyl 1H-benzimidazole-1-carboxylate, N-hexyl 1H-benzimidazole-1-carboxylate, 1H-benzimidazole-1-carboxylic acid (2-propen) methyl ester, 1H-benzimidazole-1-carboxylic acid benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-methyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-methoxy) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-ethyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-propyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-isopropyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-isobutyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-tert-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid-1-naphtalene methyl ester, 1H-benzimidazole-1-carboxylic acid cinnamyl ester, 1H-benzimidazole-1-carboxylic acid (9-fluorenylmethyl) ester, 1H-benzimidazole-1-carboxylic acid phenol ester, 1H-benzimidazole-1-carboxylic acid (4-isopropyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-tert-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (1-tert-butyl) benzyl ester, 1H-benzimidazole-carboxylic acid (1-benzyl ester, 1-benzimidazole-2-carboxylic acid (4-tert-butyl) benzyl ester, 1-benzimidazole-1-carboxylic acid (1-naphtyl) ester, 1-benzimidazole-carboxylic acid (1-naphtyl ester), 1H-benzimidazole-1-carboxylic acid (4-n-propyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (4-methylisopropyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (2, 6-dimethyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (2, 6-di-tert-butyl) phenol ester, 1- (4-trifluoromethylphenyl) -1H-benzimidazole, 1- (2, 4, 6-triisopropylsulfonyl) -1H-benzimidazole, 2-methyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-ethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-butyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-bromo-1H-benzimidazole-1-carboxylic acid methyl ester, 2-phenyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-mercapto-1H-benzimidazole-1-carboxylic acid methyl ester, 2-isopropyl-1H-benzimidazole-carboxylic acid methyl ester, 2-tert-butyl-1-carboxylic acid methyl ester, 2-ethoxy-1-benzimidazole-carboxylic acid ethyl ester, benzimidazole-1-carboxylic acid methyl ester, one or more of methyl 6-nitro-1H-benzimidazole-2-ethyl acetate-1-carboxylate, methyl 5, 6-dimethyl-1H-benzimidazole-2-ethyl acetate-1-carboxylate, methyl 1H-benzimidazole-2-thioacetate-1-carboxylate, methyl 1H-benzimidazole-6-carboxylate, methyl 2-methyl-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-methoxy-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-tert-butyl-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-diisopropylphosphine-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide.
As a specific embodiment of the present invention, preferably, the magnesium in the catalyst component is derived from a magnesium compound, the magnesium compound is a magnesium halide and/or a magnesium alkoxide compound, further preferably, the magnesium halide is magnesium chloride or hydrated magnesium chloride, the magnesium alkoxide compound is a carrier or solution prepared by mixing magnesium chloride with a C1 to C12 alcohol, still further preferably, a carrier or solution prepared by mixing magnesium chloride with a C1 to C4 alcohol, and still further preferably, ethoxymagnesium.
As a specific embodiment of the present invention, preferably, the titanium in the catalyst component is derived from a titanium compound having the general formula TiX n (OR) 4-n Wherein X is a halogen atom, more preferably a chlorine atom; n is 1-4; r is a C1-C20 alkane, more preferably a C1-C10 alkane, still more preferably n-butyl, isobutyl or 2-ethylhexyl.
As a specific embodiment of the present invention, the titanium compound is preferably at least one selected from the group consisting of titanium tetrahalide and titanium alkoxide, and more preferably at least one selected from the group consisting of titanium tetrachloride and tetrabutyl titanate.
In a second aspect, the present invention provides a catalyst comprising component (a) and component (B), and optionally component (C), the component (a) being a catalyst component according to any one of claims 1 to 5, the component (B) being an organoaluminum compound, and the component (C) being an organosilicon compound.
As a specific embodiment of the present invention, the organoaluminum compound is preferably one or more selected from the group consisting of trialkylaluminum, dialkylaluminum chloride, alkylaluminum chloride and alkylaluminoxane, more preferably one or more selected from the group consisting of trialkylaluminum, dialkylaluminum chloride, alkylaluminum chloride and alkylaluminoxane wherein the alkyl group is a C1 to C20 alkyl group, and still more preferably one or more selected from the group consisting of trialkylaluminum and dialkylaluminum chloride.
As a specific embodiment of the present invention, preferably, the organoaluminum compound is at least one selected from trimethylaluminum, triethylaluminum, tri-n-propylaluminum, triisopropylaluminum, tri-n-butylaluminum, triisobutylaluminum, trioctylaluminum, diethylaluminum monohydride, diisobutylaluminum monohydride, diethylaluminum monochloride, diisobutylaluminum monochloride, sesquiethylaluminum chloride and ethylaluminum dichloride; further preferred are triethylaluminum and/or triisobutylaluminum.
As a specific embodiment of the present invention, preferably, the organosilicon compound is a compound represented by the general formula II, the structure of the compound represented by the general formula II is as follows,
R A m Si(OR B ) 4-m
general formula II
Wherein m is more than or equal to 0 and less than or equal to 3, R A And R is B Identical or different, R A Is an alkyl, cycloalkyl, aryl, haloalkyl, amino, halogen or hydrogen atom, R B Is alkyl, cycloalkyl, aryl, haloalkyl or amine; further preferably, R A Is C1-C10 alkyl, C3-C10 cycloalkyl, C6-C10 aryl, C1-C10 haloalkyl, amino, halogen or hydrogen atom, R B Is C1-C10 alkyl, C3-C10 cycloalkyl, C6-C10 aryl, C1-C10 haloalkyl or amino; still more preferably, the organosilicon compound is selected from the group consisting of trimethylmethoxysilane, trimethylethoxysilane, trimethylphenoxysilane, tri-n-propylmethoxysilane, dimethyldimethoxysilane, di-At least one of propyldimethoxy silane, dibutyldimethoxy silane, dipentyl dimethoxy silane, diisopropyldimethoxy silane, diisobutyldimethoxy silane, dimethyldiethoxy silane, cyclohexylmethyl diethoxy silane, cyclohexylmethyl dimethoxy silane, cyclohexyldimethylmethoxy silane, hexyldiethylmethoxy silane, dicyclopentyldimethoxy silane, cyclopentyldiethylmethoxy silane, cyclopentylisopropyldimethoxy silane, cyclopentylisobutyldimethoxy silane, 4-methylcyclohexylmethyl dimethoxy silane, 4-methylcyclohexylethyldimethoxy silane, 4-methylcyclohexylpropyl dimethoxy silane, bis (4-methylcyclohexyl) dimethoxy silane, 4-methylcyclohexylpentyl dimethoxy silane, 4-methylcyclohexylcyclopentyl dimethoxy silane, diphenyldimethoxy silane, diphenyldiethoxy silane, phenyltriethoxy silane, phenyltrimethoxy silane, vinyltrimethoxy silane, tetramethoxy silane, tetraethoxy silane, tetrapropoxy silane, tetrabutoxy silane; still more preferably, the organosilicon compound is selected from at least one of cyclohexylmethyldimethoxysilane, dicyclopentyldimethoxysilane, and diisopropyldimethoxysilane.
As a specific embodiment of the present invention, the molar ratio of the components (A), (B) and (C) is preferably 1 (5-2000): 0-500, more preferably 1 (10-800): 0-300, still more preferably 1 (50-200): 0-30.
The catalyst component for olefin polymerization using the above-mentioned compound as an internal electron donor can be prepared by the following optional method:
method 1: an inert diluent may be added to a homogeneous solution of magnesium halide in the organic epoxy compound and the organic phosphorus compound. The homogeneous solution is mixed with titanium tetrahalide or its derivative, and when a precipitation-assisting agent is present in the reaction system, a solid is precipitated. And (3) carrying the compound shown in the general formula I on a solid object, and treating the solid object by using titanium tetrahalide or an inert diluent to obtain the solid catalyst component comprising titanium, magnesium, halogen, an electron donor and the like.
The organic epoxy compound preferably includes at least one of C2-C15 aliphatic alkane, alkene, diene, halogenated aliphatic alkene, oxide of diene, glycidyl ether and internal ether. Specific compounds are butylene oxide, propylene oxide, ethylene oxide, butadiene double oxide, epichlorohydrin, butylene oxide, chloropentane oxide, methyl glycidyl ether, diglycidyl ether, tetrahydrofuran, tetrahydropyran, etc. More preferably, it comprises ethylene oxide, propylene oxide, epichlorohydrin, tetrahydrofuran, tetrahydropyran.
The organic phosphorus compound preferably includes hydrocarbyl or halogenated hydrocarbyl esters of orthophosphoric acid or phosphorous acid, and specific examples of the organic phosphorus compound are trimethyl orthophosphate, triethyl orthophosphate, tributyl orthophosphoric acid, tripentyl orthophosphoric acid, trihexyl orthophosphoric acid, triheptyl orthophosphoric acid, trioctyl orthophosphoric acid, triphenyl orthophosphoric acid, trimethyl phosphite, triethyl phosphite, tributyl phosphite or benzyl phosphite, etc., more preferably tributyl orthophosphoric acid, triethyl orthophosphoric acid, etc.
The inert diluent is preferably at least one of C5-C20 alkane, cycloalkane and arene, such as hexane, heptane, octane, decane, cyclohexane, benzene, toluene, xylene or derivatives thereof, etc., more preferably hexane, toluene.
The titanium tetrahalide or its derivative may be represented by the general formula TiX n (OR) 4-n Wherein R is a C1-C20 hydrocarbon radical, X is halogen, n=1-4, preferably TiCl 4
The precipitation aid preferably includes an organic acid anhydride, an organic acid, an ether, a ketone or an ester, specifically such as acetic anhydride, phthalic anhydride, succinic anhydride, maleic anhydride, pyromellitic dianhydride, acetic acid, propionic acid, butyric acid, acrylic acid, methacrylic acid, methyl ethyl ketone, acetone, benzophenone, diethyl ether, propyl ether, butyl ether, malonate, succinic acid ester, maleic acid ester, glutaric acid ester, 2, 4-pentanediol ester, 3, 5-heptanediol ester, 9-dibenzoyl fluorene, etc., more preferably includes phthalic anhydride, malonic acid ester, (R, R) -2, 4-pentanediol ester, (S, S) -2, 4-pentanediol ester, 3, 5-heptanediol ester.
Method 2: suspending alkoxy magnesium or alkoxy magnesium chloride in inert solvent to form suspension, mixing the suspension solution with tetrahalogenated titanium or its derivative to obtain solid. And then contacting the compound shown in the general formula I with a solid substance to obtain the solid catalyst comprising titanium, magnesium, halogen, electron donor and other components.
The inert diluent is preferably at least one of C5-C20 alkane, cycloalkane and arene, such as hexane, heptane, octane, decane, cyclohexane, benzene, toluene, xylene or derivatives thereof, etc., more preferably hexane, toluene.
The titanium tetrahalide or its derivative may be represented by the general formula TiX n (OR) 4-n Wherein R is a C1-C20 hydrocarbon radical, X is halogen, n=1-4, preferably TiCl 4
Method 3: fully mixing and stirring magnesium halide or an organic magnesium compound, an alcohol compound and titanate or a titanium halide compound in an inert solvent, heating and cooling to obtain a spherical carrier or adding the inert solvent to obtain a uniform alkoxide solution. Mixing the carrier or the uniform solution with titanium tetrahalide or a derivative thereof, maintaining at a low temperature for a period of time, heating, adding the compound shown in the general formula I, treating with titanium tetrahalide or an inert diluent, treating with the compound, and finally filtering, washing and drying to obtain the solid catalyst comprising components such as titanium, magnesium, halogen, electron donor and the like.
The magnesium halide preferably includes at least one of magnesium dichloride, magnesium dibromide, magnesium diiodide, magnesium methoxychloride, magnesium ethoxychloride, magnesium propoxychloride, magnesium butoxychloride, and the like, and more preferably magnesium dichloride and/or magnesium ethoxychloride.
The organomagnesium compound preferably includes at least one of dimethyl magnesium, diethyl magnesium, dipropyl magnesium, dibutyl magnesium, methylethyl magnesium, methylpropyl magnesium, methylbutyl magnesium, ethylpropyl magnesium, ethylbutyl magnesium, dimethoxy magnesium, diethoxy magnesium, dipropoxy magnesium, ethoxyethyl magnesium, dibutoxy magnesium, diisobutoxy magnesium, and the like, more preferably dibutyl magnesium, diethyl magnesium, or diethoxy magnesium.
Method 4: the magnesium halide is dissolved in the organic epoxy compound and the organic phosphorus compound to form a uniform solution, and an inert diluent and an internal electron donor, such as the compound shown in the general formula I, can be added. Mixing the solution with titanium tetrahalide or its derivative, maintaining at low temperature for a period of time, heating, treating with titanium tetrahalide or inert diluent, treating with the compound shown in the general formula I, filtering, washing, and drying to obtain solid catalyst containing titanium, magnesium, halogen, electron donor, etc.
Method 5: the polyolefin catalyst solid components prepared according to the methods 1-4 are dispersed in a medium, and are subjected to a prepolymerization reaction with a small amount of propylene or ethylene gas or ethylene-propylene mixture gas with different proportions to prepare a prepolymerization catalyst, wherein the prepolymerization catalyst can be stored and dispersed in the medium, and can also be used after filtration, washing and pumping.
The dispersion medium may be at least one of C5-C31 alkane, cycloalkane and arene such as hexane, heptane, octane, decane, cyclohexane, benzene, toluene, xylene or derivatives thereof, white oil, etc., or at least one of lubricating oil products such as simethicone, cyclomethicone, aminosilicone, polymethylphenylsiloxane, polyether polysiloxane copolymer, etc., wherein the dispersion medium more preferably includes hexane, white oil.
The prepolymerization temperature may range from-30℃to 100℃and more preferably from 0 to 40 ℃. The ratio of the ethylene-propylene mixture is from 1:100 to 100:1 (v/v), more preferably from 1:20 to 20:1.
A small amount of AlR with the general formula can be added in the preparation process of the prepolymerized catalyst K X 3-K Wherein R is hydrogen or a hydrocarbon group of 1 to 20 carbon atoms, X is halogen, and K is an integer of 1 to 3; specifically, trimethylaluminum, triethylaluminum, triisobutylaluminum, diethylaluminum chloride and sesquiethylaluminum chloride are selected, and triethylaluminum and triisobutylaluminum are preferable. And optionally organosilicon compounds such as cyclohexylmethyldimethoxysilane. The prepolymerized catalyst can be stored for a long period of time in an inert environment.
In a third aspect, the present invention provides a process for the polymerisation of olefins selected from one or more of ethylene, propylene, butene-1, 4-methyl-1-pentene, 1-hexene, in the presence of the above catalyst component or catalyst. The olefin polymerization method is carried out according to a known polymerization method, is suitable for gas phase, liquid phase or gas-liquid combination reaction, and is particularly suitable for a prepolymerized catalyst component prepared by the method 5 for a process device without prepolymerization.
As a specific embodiment of the present invention, preferably, the polymerization is propylene homo-polymerization or copolymerization of ethylene and an α -olefin, further preferably, the polymerization temperature is 0 to 150 ℃, still further preferably 60 to 90 ℃.
In summary, the catalyst component or the catalyst provided by the invention is suitable for the field of olefin polymerization, in particular for the field of propylene polymerization. When the catalyst is used for olefin polymerization reaction, satisfactory catalyst activity and stereospecificity of the catalyst can be obtained, wherein the polymer has wide molecular weight distribution, and the processability of the polymer can be effectively improved.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only for illustrating the present invention and should not be construed as limiting the scope of the present invention. The specific conditions are not noted in the examples and are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
The testing method comprises the following steps:
1. polymer Melt Index (MI): according to GB/T3682-2000;
2. propylene polymer isotacticity index (i.i.): determination by n-heptane extraction: 2g of dried polymer sample is put in an extractor and is extracted by boiling heptane for 6 hours, and the ratio of the weight (g) of the polymer obtained by drying the residue to constant weight to 2 (g) is isotacticity;
3. polymer molecular weight distribution MWD (mwd=mw/Mn): PL-GPC220 was used, with trichlorobenzene as solvent, at 150℃C (standard: polystyrene, flow rate: 1.0mL/min, column: 3xPlgel 10 μm MlxED-B300 x7.5 nm).
4. Activity calculation: catalyst activity= (mass of polyolefin produced)/(mass of catalyst solid component) g/g.
Examples
(1) Preparation of the compound:
the preparation of the compounds is mainly described in the literature Organometallics 2021,40,14,2265-2271, chem. Commun.,2014,50,4751-4754 and International patent WO 2015039606A 1, some of which are modified and adapted.
EXAMPLE 1 Synthesis of Compound 1H-benzimidazole-1-carboxylic acid methyl ester
1.86g of sodium hydride (60% dispersed in mineral oil) was rapidly weighed and placed in a 250mL three-necked flask, connected with nitrogen and a balance addition funnel, and the reaction apparatus was placed in an ice bath at 0deg.C, and repeatedly evacuated and purged with nitrogen to exhaust air. 50mL of anhydrous tetrahydrofuran was added to the three-necked flask, and stirring was started. 5g of benzimidazole was weighed and dispersed in another 30mL of anhydrous tetrahydrofuran and transferred to an equilibrated addition funnel under nitrogen. Dropwise adding benzimidazole solution into sodium hydride dispersion liquid at 0 ℃ for 30 minutes; after which the temperature was slowly raised to room temperature and stirring was continued for 1 hour. Methyl chloroformate 4.4g was dispersed in 10mL anhydrous tetrahydrofuran and added dropwise to the reaction flask at room temperature using a syringe. Stirring was continued for 15 minutes and then the reaction was refluxed at a temperature of 4 hours. The reaction was then quenched with a small amount of dilute hydrochloric acid (1N, 50 mL), and the reaction solution was extracted with ethyl acetate and water at least three times. The organic phase was dried over sodium sulfate, concentrated under reduced pressure, and purified by silica gel column chromatography to give a yellow oily liquid, which was dried by suction to give 4.8 g of the product in 64% yield. 1 H-NMR(500MHz,d 6 -DMSO):δ8.15(s,1H),7.82~7.78(m,1H),7.46~7.34(m,3H),3.45(s,3H)。
EXAMPLE 2 Synthesis of the Compound N, N-diisopropyl-1H-benzimidazole-1-carboxamide
The preparation method is similar to that of example 1, only methyl chloroformate is replaced by N, N-diisopropylamine acyl chloride, the reaction time of heating reflux is prolonged to 8 hours, and the yield is 78%. 1 H-NMR(500MHz,d 6 -DMSO):δ8.11(s,1H),7.89~7.82(m,1H),7.52~7.44(m,3H),3.54~3.34(m,2H),1.53~1.34(m,12H)。
EXAMPLE 3 Synthesis of Compound 1H-benzimidazole-1-carboxylic acid (9-fluorenylmethyl) ester
The preparation method is similar to that of example 1, the compound methyl chloroformate is replaced by (9-fluorenylmethyl) chloroformate, the reaction time of heating reflux is prolonged to 16 hours, and the product is purified by ethanol recrystallization, and the yield is 32%. 1 H-NMR(500MHz,d 6 -DMSO):δ8.13(s,1H),7.89(s,1H),7.71~7.63(m,3H),7.55~7.11(m,9H),4.25(d,2H)。
EXAMPLE 4 Compound 1-phenyl-1' - (1H-benzimidazolyl) -methanone
2g of benzimidazole, 2.7g of benzaldehyde and 0.6g of potassium iodide are sequentially added into a 100mL double-mouth bottle, and a magneton is placed into the bottle, wherein the adding volume ratio is 3:1 and 50mL of a mixed solvent of ethylene glycol dimethyl ether and water, and stirring was started. After stirring for 30 minutes, 6.5g of a 70% strength aqueous solution of t-butyl hydroperoxide was slowly added by means of a syringe, and a condenser was connected to the upper outlet of the double-necked flask. The temperature of the reaction flask was gradually raised by using an oil bath, and the reaction was continued for 16 hours at 95 ℃. After the reaction is finished, the reaction is carried out The flask was cooled to room temperature, quenched with a small amount of dilute hydrochloric acid (1 n,10mL, n being the equivalent concentration, representing the number of mL equivalents of solute in 1L of solution), and repeatedly extracted and washed with ethyl acetate and brine at least three times. The organic phase is dried by anhydrous sodium sulfate, decompressed and concentrated, and then separated and purified by a silica gel chromatographic column to obtain a pure product with the yield of 58 percent. 1 H-NMR(500MHz,d 6 -DMSO):δ8.18(s,1H),8.15~8.12(m,1H),7.79~7.75(m,1H),7.71(d,2H),7.67~7.61(m,1H),7.58~7.52(m,2H),7.48~7.42(m,2H)。
EXAMPLE 5 Compound 5-methyl-1H-benzimidazole-1-carboxylic acid methyl ester
The preparation was carried out in analogy to example 1, in which the compound benzimidazole was replaced by 5-methylbenzimidazole in 62% yield. 1 H-NMR(500MHz,d 6 -DMSO):δ8.12(s,1H),7.79~7.71(m,1H),7.42~7.35(m,2H),3.42(s,3H),2.37(s,3H)。
EXAMPLE 6 Compound 2-phenyl-1H-benzimidazole-1-carboxylic acid methyl ester
The preparation was carried out in analogy to example 1, in which the compound benzimidazole was replaced by 2-phenylbenzimidazole in 62% yield. 1 H-NMR(500MHz,d 6 -DMSO):7.81~7.79(m,1H),7.63~7.58(m,2H),7.53~7.48(m,3H),7.21~7.15(m,3H),3.37(s,3H)。
EXAMPLE 7 Compound 2-benzimidazole ethyl acetate-1-carboxylic acid methyl ester
The preparation was carried out in analogy to example 1, in which the compound benzimidazole was replaced by ethyl 2-benzimidazole acetate in 22% yield. 1 H-NMR(500MHz,d 6 -DMSO):7.87~7.85(m,1H),7.70~7.63(m,3H),4.21~4.15(q,2H),3.47(s,3H),2.32(s,2H),1.22(t,3H)。
EXAMPLE 8 Synthesis of the Compound 2-diisopropylphosphine-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide
2.8g of the compound synthesized in example 2 was added to a 250mL double-necked flask which had been sufficiently replaced with nitrogen, anhydrous tetrahydrofuran was added, the temperature was controlled to-78℃with a bath of liquid nitrogen and acetone, 5mL of n-butyllithium (2.5 mol/L in n-hexane) was slowly dropped into the reaction system, and after stirring for 15 minutes, the temperature was slowly raised to room temperature, and stirring was continued at room temperature for 1 hour, and the reaction solution was cooled to-78℃and 2mL of chlorodiisopropylphosphine was slowly dropped, and the temperature was raised and stirred overnight. After the completion of the reaction, the reaction was quenched with a small amount of diluted hydrochloric acid (1N, 100 mL), and the reaction mixture was extracted with ethyl acetate and water for at least three times. The organic phase is dried over sodium sulphate, concentrated under reduced pressure and purified by recrystallisation from diethyl ether/n-hexane to give 1.8g of the product in 43% yield. 1 H-NMR(500MHz,d 6 -DMSO):δ7.85~7.83(m,1H),7.71~7.66(m,3H),3.55~3.48(m,2H),1.57~1.38(m,12H),1.29~1.18(m,14H)。
(2) Preparation of the catalyst
Example 9
To a reactor fully replaced with high purity nitrogen, 4.8g of magnesium chloride, 95mL of toluene, 4mL of Epichlorohydrin (ECH), 12.5mL of tributyl phosphate (TBP) were added in this order, and the temperature was raised to 50℃with stirring and maintained for 2.5 hours. After the solid is completely dissolved, 1.4g of phthalic anhydride is added, the solution is continuously maintained for 1 hour, cooled to below-25 ℃, tiCl is added dropwise within 1 hour 4 60mL, slowly warmed to 80 ℃, gradually precipitating a solid, adding 6mmol of the compound prepared in example 1, and maintaining the temperature for 1 hour. After hot filtration, 150mL of toluene was added and washed twice to give a solid. 100mL of toluene was added, the temperature was raised to 110℃and three washes were performed for 10 minutes each. Then 60mL of hexane is added for three times of washing,after drying in vacuo, 6.7g of a catalyst solid was obtained, which contained 2.78wt% of Ti, 18.55wt% of Mg, 35.81wt% of Cl and 9.8wt% of an internal electron donor.
Example 10
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 2.
Example 11
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 3.
Example 12
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 4.
Example 13
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 5.
Example 14
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 6.
Example 15
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 7.
Example 16
As in example 9, only the methyl 1H-benzimidazole-1-carboxylate was replaced with the compound of example 8.
Example 17
4.8g of anhydrous magnesium chloride, 19.5g of isooctanol and 19.5g of decane solvent were charged in a 500ml reactor equipped with a stirrer under nitrogen protection, heated to 130℃and reacted for 1.5 hours until the magnesium chloride was completely dissolved. 1.4g of phthalic anhydride was added thereto, and the reaction was continued at 130℃for 1 hour to obtain an alcohol compound, which was cooled to room temperature. The above alcohol was added dropwise to 120ml of titanium tetrachloride solution pre-chilled to-22℃under nitrogen protection, the temperature was slowly raised to 100℃and 6mmol of the compound of the structure described in example 8 was added thereto, and the temperature was raised to 110℃for 2 hours. The mixture was filtered while it was still hot, 120ml of titanium tetrachloride was added thereto, and the mixture was reacted at 110℃for 2 hours, followed by filtration. The solid particles were washed 4 times with anhydrous hexane and dried under vacuum to give 6.6g of a catalyst solid composition comprising 2.55wt% of Ti, 20.31wt% of Mg, 38.8wt% of Cl and 11.3wt% of an internal electron donor.
Example 18
Into a reactor fully replaced by high-purity nitrogen, 300mL of TiCl was introduced 4 Cooling to-20deg.C, adding magnesium chloride alkoxide carrier 7.0g (see patent CN 1330086A), stirring, heating to 40deg.C in stages, adding 6mmol of the structural compound described in example 8, maintaining the temperature for 2 hr, and filtering. TiCl is added again 4 100mL was warmed to 110℃and treated three times. 60mL of hexane is added for three times, and 5.6g of catalyst solid component which comprises 1.73wt% of Ti, 23.87wt% of Mg, 40.33wt% of Cl and 12.5wt% of internal electron donor is obtained after vacuum drying.
Example 19
In a reactor fully replaced by high purity nitrogen, 300mL TiCl was added 4 Cooling to-20 ℃, adding 7.0g of magnesium ethoxide, heating to 40 ℃ in stages under stirring, adding 6mmol of the compound with the structure described in example 8, maintaining the temperature for 3 hours, and filtering. TiCl is added 4 100mL was warmed to 110℃and treated three times. 60mL of hexane is added for three times, and 5.8g of catalyst solid component which comprises 2.43wt% of Ti, 21.13wt% of Mg, 33.71wt% of Cl and 10.2wt% of internal electron donor is obtained after drying.
Example 20
500mL of glass reaction vessel was purged overnight with high-purity nitrogen, about 300mL of n-hexane was added under slight positive pressure, stirring was started at 850rpm, and the temperature of the reaction system was controlled at 10℃with an oil bath. After the reaction system was stabilized, the catalyst sample in example 10 was dissolved in a small amount of hexane and added to the reaction vessel, and a small amount of triethylaluminum was added, al/Ti (mol/mol) =3 was controlled, a certain amount of propylene was introduced, and the prepolymerization was performed until the propylene was completely consumed, and a prepolymerization catalyst having a prepolymerization multiple of about 2 was obtained based on the propylene gas consumption. After the reaction is finished, the pressure is released, and the hexane solution in which the prepolymerized catalyst is dispersed is collected under the protection of inert gas.
Example 21
As in example 20, only the reaction solvent n-hexane was replaced with white oil.
Example 22
As in example 20, the solvent was drained only after the completion of the reaction.
Comparative example 1
To a reactor fully replaced with high purity nitrogen, 4.8g of magnesium chloride, 95mL of toluene, 4mL of Epichlorohydrin (ECH), 12.5mL of tributyl phosphate (TBP) were added in this order, and the temperature was raised to 50℃with stirring and maintained for 2.5 hours. After the solid was completely dissolved, 1.4g of phthalic anhydride was added and the reaction was continued for 1 hour. Cooling the solution to below-25 ℃, and dripping TiCl in 1 hour 4 Slowly heating to 80 ℃, gradually precipitating a solid, adding 6mmol of di-n-butyl phthalate (DNBP), and maintaining the temperature for 1 hour. After hot filtration, 150mL of toluene was added and washed twice to give a solid. 100mL of toluene was added, the temperature was raised to 110℃and three washes were performed for 10 minutes each. And adding 60mL of hexane, washing for three times, and drying to obtain the catalyst solid component.
Polymerization reaction
The method adopts an atmospheric slurry polymerization method: the 500mL glass reaction kettle is firstly purged with high-purity nitrogen overnight, propylene gas is used for full replacement in advance before reaction feeding, about 200mL of n-decane is added under the condition of micro positive pressure of the propylene gas, stirring is started, the rotating speed is 2000rpm, and the temperature of a reaction system is controlled at 70 ℃ by using an oil bath. After the polymerization reaction system is stabilized, the weighed dry powder of the catalyst sample in the example or the comparative example is dissolved by a small amount of hexane, or a certain volume of prepolymerized catalyst white oil or hexane slurry with known concentration is extracted, and is added into a reaction kettle, triethylaluminum and tetraethoxysilane are simultaneously added, al/Ti (mol/mol) =100, al/Si (mol/mol) =25 are controlled, propylene pressure is kept between 0.04 and 0.05MPa, and polymerization is carried out for 2 hours. After the reaction is finished, the pressure is released, the polypropylene product is collected by filtration, and the catalyst activity is calculated after drying and weighing.
The resulting polymerization data are shown in Table 1.
TABLE 1
/>
As can be seen from examples 9 to 19 and comparative example 1 above, when the catalyst of the present invention is used for propylene polymerization, the obtained polymer has a higher melt index and a broad molecular weight distribution, and the processability of the polymer is effectively improved.
Any numerical value recited in this disclosure includes all values incremented by one unit from the lowest value to the highest value if there is only a two unit interval between any lowest value and any highest value. For example, if the amount of one component, or the value of a process variable such as temperature, pressure, time, etc., is stated to be 50-90, it is meant in this specification that values such as 51-89, 52-88 … …, and 69-71, and 70-71 are specifically recited. For non-integer values, 0.1, 0.01, 0.001 or 0.0001 units may be considered as appropriate. This is only a few examples of the specific designations. In a similar manner, all possible combinations of numerical values between the lowest value and the highest value enumerated are to be considered to be disclosed in this application.
It should be noted that the above-described embodiments are only for explaining the present invention and do not constitute any limitation of the present invention. The invention has been described with reference to exemplary embodiments, but it is understood that the words which have been used are words of description and illustration, rather than words of limitation. Modifications may be made to the invention as defined in the appended claims, and the invention may be modified without departing from the scope and spirit of the invention. Although the invention is described herein with reference to particular means, materials and embodiments, the invention is not intended to be limited to the particulars disclosed herein, as the invention extends to all other means and applications which perform the same function.

Claims (15)

1. A catalyst component for olefin polymerization is characterized in that the catalyst component contains magnesium, titanium, halogen and an internal electron donor, the internal electron donor is a compound shown in a general formula I,
in the general formula I, R 2 ~R 5 The same or different, each independently is hydrogen, C1-C30 alkyl, C2-C30 alkenyl, C6-C30 halogen substituted or unsubstituted aryl, C4-C30 heterocyclic group, halogen atom, alkoxy or substituent containing nitrogen atom; r is R 1 、R 6 The same or different are each independently hydrogen, a C1-C15 hydrocarbon group or a heteroatom-containing substituent; the heteroatom is selected from at least one of nitrogen, sulfur, oxygen, phosphorus, and silicon.
2. The catalyst component according to claim 1, characterized in that in formula I, R 2 ~R 5 The same or different, each independently is a C1-C10 alkyl group, a C2-C15 alkenyl group, a C6-C15 halogen substituted or unsubstituted aromatic group, a C4-C15 heterocyclic group, a halogen atom, an alkoxy group or a substituent containing a nitrogen atom; preferably, each is independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl, methoxy, isopropyl ether, tert-butyl ether, phenyl, halophenyl, naphthyl, biphenyl, nitro, amino, pyridine, thiophene, or quinoline.
3. The catalyst component according to claim 1 or 2, characterized in that in formula I, R 6 is-O-R 7 or-N-R 8 (-R 9 ) Wherein R is 7 、R 8 And R is 9 Each independently is hydrogen, a C1-C30 alkyl group, a C2-C30 alkenyl group, a C6-C30 halogen substituted or unsubstituted aryl group, a C4-C30 heterocyclic group, a halogen atom, an alkoxy group, or a substituent containing a nitrogen atom; preferably, R 7 、R 8 And R is 9 Each independently ofThe standing is hydrogen, C1-C10 alkyl, C2-C15 alkenyl, C6-C15 halogen substituted or unsubstituted aryl, C4-C15 heterocyclic group, halogen atom, nitro, amino or alkoxy.
4. A catalyst component according to any one of claims 1 to 3, characterized in that the magnesium element content in the catalyst component is 1 to 89.7wt%, the titanium element content is 0.2 to 20wt%, the halogen content is 10 to 80wt%, and the internal electron donor content is 0.1 to 30wt%, based on the mass of the catalyst component; preferably, the content of magnesium element is 10-45 wt%, the content of titanium element is 1.5-10 wt%, the content of halogen is 20-45 wt%, and the content of internal electron donor is 1-15 wt%; more preferably, the content of magnesium element is 15wt% to 25wt%, the content of titanium element is 2wt% to 5wt%, the content of halogen is 30wt% to 41wt%, and the content of internal electron donor is 5wt% to 13wt%. .
5. The catalyst component according to any of claims 1 to 4, characterized in that the compound of formula I is selected from the group consisting of 1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-diphenyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-ethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-ethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-ethylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (4-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (2-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (4-ethylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5, 6-bis (3-ethylphenyl) -1-carboxylic acid methyl ester, 1H-benzimidazole-carboxylic acid methyl ester, 1-bis (3-ethylphenyl) -1-carboxylic acid methyl ester, 5, 6-bis (2-isopropylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-n-butylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4-methylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4, 6-trimethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (4-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (4-isopropylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (2, 4-dimethylphenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5-phenyl-6- (2, 4, 6-trimethylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (2-n-propylphenyl) -1H-benzimidazole-carboxylic acid methyl ester, 5-phenyl-1-benzimidazole-carboxylic acid methyl ester, 5-phenyl-6- (2-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (3-chlorophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (4-nitrophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-bis (2, 4, 6-trinitrophenyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-dimethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-diethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-isopropyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-di-n-butyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-di-isobutyl-1H-benzimidazole-carboxylic acid methyl ester, 5, 6-trinitrophenyl-1-carboxylic acid methyl ester, 5, 6-dimethyl-1-benzimidazole-carboxylic acid methyl ester, 5, 6-dimethyl-1-carboxylic acid methyl ester, 5, 1-dimethyl-1-benzimidazole-carboxylic acid methyl ester, 5, 1-dimethyl-1-carboxylic acid methyl ester, 5, 6-bis (1-methylpentyl) -1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-di-n-pentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-dipentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-isopropyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-butyl-1H-benzimidazole-1-carboxylic acid methyl ester 5-methyl-6-isobutyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-n-pentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-methyl-6-isopentyl-1H-benzimidazole-1-carboxylic acid methyl ester, 5-ethyl-6-n-propyl-1H-benzimidazole-1-carboxylic acid methyl ester, 6-methyl-1H-benzimidazole-1-carboxylic acid methyl ester, 6-nitro-1H-benzimidazole-1-carboxylic acid methyl ester, 5, 6-dinitro-1H-benzimidazole-1-carboxylic acid methyl ester, 1' -carbonylbis (1H-benzimidazole), 1,1' -carbonylbis (5-methyl-1H-benzimidazole), 1' -carbonylbis (5-ethyl-1H-benzimidazole), 1' -carbonylbis (5-isopropyl-1H-benzimidazole), 1-phenyl-1 ' - (1H-benzimidazolyl) -methanone, 1- (1H-imidazolyl) -1' - (1H-benzimidazolyl) -methanone, 1- (5-methyl-1H-imidazolyl) -1' - (5-methyl-1H-benzimidazolyl) -methanone, 1- (2-ethyl-3-methyl-1H-imidazolyl) -1' - (1H-benzimidazolyl) -methanone, 1H-benzimidazole-1-carboxamide, N, N-diphenyl-1H-benzimidazole-1-carboxamide, N-bis (4-methylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-methylphenyl) -1H-benzimidazole-1-carboxamide, 4, 5-bis (3-methylphenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-ethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-N-butylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (2, 4-methylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (4-N-propylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (4-isopropylphenyl) -1H-benzimidazole-1-carboxamide, N-phenyl-N- (2, 4-dimethylphenyl) -1H-benzimidazole-1-carboxamide, N-bis (4-chlorophenyl) -1H-benzimidazole-1-carboxamide, N-bis (2-chlorophenyl) -1H-benzimidazole-1-carboxamide, N-bis (3-chlorophenyl) -1H-benzimidazole-1-carboxamide, N, N-bis (4-nitrophenyl) -1H-benzimidazole-1-carboxamide, N-dimethyl-1H-benzimidazole-1-carboxamide, N-diethyl-1H-benzimidazole-1-carboxamide, N-di-N-propyl-1H-benzimidazole-1-carboxamide, N, N-diisopropyl-1H-benzimidazole-1-carboxamide, N-di-N-butyl-1H-benzimidazole-1-carboxamide, N-diisobutyl-1H-benzimidazole-1-carboxamide, N, n-bis (1-methylpropyl) -1H-benzimidazole-1-carboxamide, N-bis (1-methylbutyl) -1H-benzimidazole-1-carboxamide, N-bis (1-methylpentyl) -1H-benzimidazole-1-carboxamide, N-di-N-pentyl-1H-benzimidazole-1-carboxamide, N, N-dipentyl-1H-benzimidazole-1-carboxamide, N-methyl-N-N-propyl-1H-benzimidazole-1-carboxamide, N-methyl-N-isopropyl-1H-benzimidazole-1-carboxamide, N-methyl-N-N-butyl-1H-benzimidazole-1-carboxamide, ethyl 1H-benzimidazole-1-carboxylate, trifluoroethyl 1H-benzimidazole-1-carboxylate, propyl 1H-benzimidazole-1-carboxylate, N-butyl 1H-benzimidazole-1-carboxylate, isobutyl 1H-benzimidazole-1-carboxylate, N-pentyl 1H-benzimidazole-1-carboxylate, isopentyl 1H-benzimidazole-1-carboxylate, 2-methylbutyl 1H-benzimidazole-1-carboxylate, 2-dimethylpropyl 1H-benzimidazole-1-carboxylate, N-hexyl 1H-benzimidazole-1-carboxylate, 1H-benzimidazole-1-carboxylic acid (2-propen) methyl ester, 1H-benzimidazole-1-carboxylic acid benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-methyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-methoxy) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-ethyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-propyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-isopropyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-isobutyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-tert-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid-1-naphtalene methyl ester, 1H-benzimidazole-1-carboxylic acid cinnamyl ester, 1H-benzimidazole-1-carboxylic acid (9-fluorenylmethyl) ester, 1H-benzimidazole-1-carboxylic acid phenol ester, 1H-benzimidazole-1-carboxylic acid (4-isopropyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (4-tert-butyl) benzyl ester, 1H-benzimidazole-1-carboxylic acid (1-tert-butyl) benzyl ester, 1H-benzimidazole-carboxylic acid (1-benzyl ester, 1-benzimidazole-2-carboxylic acid (4-tert-butyl) benzyl ester, 1-benzimidazole-1-carboxylic acid (1-naphtyl) ester, 1-benzimidazole-carboxylic acid (1-naphtyl ester), 1H-benzimidazole-1-carboxylic acid (4-n-propyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (4-n-butyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (4-methylisopropyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (2, 6-dimethyl) phenol ester, 1H-benzimidazole-1-carboxylic acid (2, 6-di-tert-butyl) phenol ester, 1- (4-trifluoromethylphenyl) -1H-benzimidazole, 1- (2, 4, 6-triisopropylsulfonyl) -1H-benzimidazole, 2-methyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-ethyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-butyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-bromo-1H-benzimidazole-1-carboxylic acid methyl ester, 2-phenyl-1H-benzimidazole-1-carboxylic acid methyl ester, 2-mercapto-1H-benzimidazole-1-carboxylic acid methyl ester, 2-isopropyl-1H-benzimidazole-carboxylic acid methyl ester, 2-tert-butyl-1-carboxylic acid methyl ester, 2-ethoxy-1-benzimidazole-carboxylic acid ethyl ester, benzimidazole-1-carboxylic acid methyl ester, one or more of methyl 6-nitro-1H-benzimidazole-2-ethyl acetate-1-carboxylate, methyl 5, 6-dimethyl-1H-benzimidazole-2-ethyl acetate-1-carboxylate, methyl 1H-benzimidazole-2-thioacetate-1-carboxylate, methyl 1H-benzimidazole-6-carboxylate, methyl 2-methyl-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-methoxy-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-tert-butyl-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide, 2-diisopropylphosphine-1H-benzimidazole-1- (N, N-diisopropyl) carboxamide.
6. The catalyst component according to any one of claims 1 to 5, characterized in that the magnesium in the catalyst component is derived from a magnesium compound, which is a magnesium halide and/or a magnesium alkoxide compound, preferably the magnesium halide is magnesium chloride or hydrated magnesium chloride, and the magnesium alkoxide compound is a carrier or solution prepared by mixing magnesium chloride with a C1-C12 alcohol, more preferably a carrier or solution prepared by mixing magnesium chloride with a C1-C4 alcohol, even more preferably ethoxymagnesium.
7. The catalyst component according to any of claims 1 to 6, wherein the titanium in the catalyst component is derived from a titanium compound of the general formula TiX n (OR) 4-n Wherein X is a halogen, preferably a chlorine atom; n is 1-4; r is a C1-C20 alkane, preferably a C1-C10 alkane, more preferably n-butyl, isobutyl or 2-ethylhexyl.
8. The catalyst component according to any of claims 1 to 7, characterized in that the titanium compound is selected from at least one of titanium tetrahalides, alkoxy titanium, preferably from at least one of titanium tetrachloride, tetrabutyl titanate.
9. A catalyst comprising component (a) and component (B), and optionally component (C), wherein component (a) is a catalyst component according to any one of claims 1 to 8, component (B) is an organoaluminum compound, and component (C) is an organosilicon compound.
10. The catalyst according to claim 9, wherein the organoaluminum compound is selected from one or more of trialkylaluminum, dialkylaluminum chloride, alkylaluminum oxyalkyl, preferably one or more of trialkylaluminum, dialkylaluminum chloride, alkylaluminum oxyalkyl is a C1-C20 alkyl group, more preferably one or more of trialkylaluminum and dialkylaluminum chloride.
11. The catalyst according to claim 9 or 10, wherein the organoaluminum compound is selected from at least one of trimethylaluminum, triethylaluminum, tri-n-propylaluminum, triisopropylaluminum, tri-n-butylaluminum, triisobutylaluminum, trioctylaluminum, diethylaluminum monohydride, diisobutylaluminum monohydride, diethylaluminum monohydride, ethylaluminum sesquichloride and ethylaluminum dichloride; preferably triethylaluminium and/or triisobutylaluminium.
12. The catalyst according to any one of claims 9 to 11, wherein the organosilicon compound is a compound of the general formula II, the structure of the compound of the general formula II is as follows,
R A m Si(OR B ) 4-m
general formula II
Wherein m is more than or equal to 0 and less than or equal to 3, R A Is an alkyl, cycloalkyl, aryl, haloalkyl, amino, halogen or hydrogen atom, R B Is alkyl, cycloalkyl, aryl, haloalkyl or amine; preferably, R A Is C1-C10 alkyl, C3-C10 cycloalkyl, C6-C10 aryl, C1-C10 haloalkyl, amino, halogen or hydrogen atom, R B Is C1-C10 alkyl, C3-C10 cycloalkyl, C6-C10 aryl, C1-C10 haloalkyl or amino; more preferably, the organosilicon compound is selected from the group consisting of trimethylmethoxysilane, trimethylethoxysilane, trimethylphenoxysilane, tri-n-propylmethoxysilane, and dimethylAt least one of dimethoxysilane, dipropyldimethoxysilane, dibutyldimethoxysilane, dipentyldimethoxysilane, diisopropyldimethoxysilane, diisobutyldimethoxysilane, dimethyldiethoxysilane, cyclohexylmethyldiethoxysilane, cyclohexylmethyldimethoxysilane, cyclohexyldimethylmethoxysilane, hexyldiethylmethoxysilane, dicyclopentyldimethoxysilane, cyclopentyldiethylmethoxysilane, cyclopentylisopropyldimethoxysilane, cyclopentylisobutyldimethoxysilane, 4-methylcyclohexylmethyldimethoxysilane, 4-methylcyclohexylethyldimethoxysilane, 4-methylcyclohexylpropyldimethoxysilane, bis (4-methylcyclohexyl) dimethoxysilane, 4-methylcyclohexylpentylmethoxysilane, 4-methylcyclohexylcyclopentyldimethoxysilane, diphenyldimethoxysilane, diphenyldiethoxysilane, phenyltriethoxysilane, phenyltrimethoxysilane, vinyltrimethoxysilane, tetramethoxysilane, tetraethoxysilane, tetrapropoxysilane, tetrabutoxysilane; more preferably, the organosilicon compound is at least one selected from the group consisting of cyclohexylmethyldimethoxysilane, dicyclopentyldimethoxysilane, and diisopropyldimethoxysilane.
13. Catalyst according to any one of claims 9 to 12, characterized in that the molar ratio of components (a), (B) and (C) is 1 (5-2000): (0-500), preferably 1 (10-800): (0-300), more preferably 1 (50-200): (0-30).
14. A process for the polymerization of olefins, characterized in that said olefins are polymerized in the presence of the catalyst component according to any of claims 1 to 8 or the catalyst according to any of claims 9 to 13, said olefins being selected from one or more of ethylene, propylene, butene-1, 4-methyl-1-pentene, 1-hexene.
15. The process according to claim 14, characterized in that the polymerization is a propylene homo-polymerization or a copolymerization of ethylene with an α -olefin, preferably the polymerization temperature is 0 to 150 ℃, more preferably 60 to 90 ℃.
CN202210827412.7A 2022-07-13 2022-07-13 Catalyst component for olefin polymerization, catalyst and application thereof Pending CN117430738A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210827412.7A CN117430738A (en) 2022-07-13 2022-07-13 Catalyst component for olefin polymerization, catalyst and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210827412.7A CN117430738A (en) 2022-07-13 2022-07-13 Catalyst component for olefin polymerization, catalyst and application thereof

Publications (1)

Publication Number Publication Date
CN117430738A true CN117430738A (en) 2024-01-23

Family

ID=89546758

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210827412.7A Pending CN117430738A (en) 2022-07-13 2022-07-13 Catalyst component for olefin polymerization, catalyst and application thereof

Country Status (1)

Country Link
CN (1) CN117430738A (en)

Similar Documents

Publication Publication Date Title
CN107629153B (en) Catalyst component for olefin polymerization, preparation method thereof, catalyst for olefin polymerization and application thereof
US6342568B1 (en) Metallocene compound, and process for preparing polyolefin by using it
JP2019090051A (en) Catalyst composition for olefin polymerization and application of the same
CN108503733B (en) Olefin polymerization catalyst and preparation method thereof
JPH083215A (en) Method for polymerizing alpha-olefin
US8541332B2 (en) Catalyst for polymerization of olefins comprising thienyl-substituted silanes
CN107344973B (en) Catalyst component for olefin polymerization, catalyst system and application thereof
CN116854848A (en) Preparation method of ultra-high molecular weight poly alpha-olefin
CN117430738A (en) Catalyst component for olefin polymerization, catalyst and application thereof
CN112661882B (en) Application of cyclohexene-1,2-dicarboxylic acid ester compound
CN112661883B (en) Solid catalyst component for preparing polyolefin, catalyst system and application thereof
JP3443990B2 (en) α-Olefin polymerization method
CN112661881B (en) Olefin polymerization catalyst component, catalyst system and olefin polymerization method
CN112300304B (en) Catalyst system for olefin polymerization and prepolymerized catalyst composition
CN111234062B (en) Catalyst system for olefin polymerization and use thereof
JPS5817206B2 (en) Ethylene polymerization method
CN117430737A (en) Catalyst component for olefin polymerization, catalyst and application thereof
JP2006299069A (en) Solid catalyst component for olefin polymerization, olefin polymerization catalyst and method for producing olefin polymer
CN114456290B (en) Catalyst system for olefin polymerization and prepolymerized catalyst composition
CN111072815A (en) Catalyst component and catalyst for olefin polymerization, application thereof and olefin polymerization method
CN114456286B (en) Catalyst system for olefin polymerization and application thereof
CN112300302B (en) Twelve-membered ring compound and application thereof
CN112300303B (en) Catalyst system for olefin polymerization and application thereof
JPH1112315A (en) Solid catalyst component for polymerizing olefin, catalyst for polymerizing olefin and production of olefin polymer
CN113831434B (en) Catalyst for olefin polymerization and olefin polymerization method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination